Clinical Experiences of redo-CABG

관상동맥우회 재수술의 임상적 고찰

  • Lim, Sang-Hyun (Division of Cardiovascular Surgery, Yonsei Cardiovascular Center, Yonsei University College of Medicine) ;
  • Kwak, Young-Tae (Division of Cardiovascular Surgery, Yonsei Cardiovascular Center, Yonsei University College of Medicine) ;
  • Lee, Sak (Division of Cardiovascular Surgery, Yonsei Cardiovascular Center, Yonsei University College of Medicine) ;
  • Chang, Byung-Chul (Division of Cardiovascular Surgery, Yonsei Cardiovascular Center, Yonsei University College of Medicine) ;
  • Kang, Meyun-Shick (Division of Cardiovascular Surgery, Yonsei Cardiovascular Center, Yonsei University College of Medicine) ;
  • Cho, Bum-Koo (Division of Cardiovascular Surgery, Yonsei Cardiovascular Center, Yonsei University College of Medicine) ;
  • Yoo, Kyung-Jong (Division of Cardiovascular Surgery, Yonsei Cardiovascular Center, Yonsei University College of Medicine)
  • 임상현 (연세대학교 의과대학 심장혈관병원 심장혈관 외과) ;
  • 곽영태 (연세대학교 의과대학 심장혈관병원 심장혈관 외과) ;
  • 이삭 (연세대학교 의과대학 심장혈관병원 심장혈관 외과) ;
  • 장병철 (연세대학교 의과대학 심장혈관병원 심장혈관 외과) ;
  • 강면식 (연세대학교 의과대학 심장혈관병원 심장혈관 외과) ;
  • 조범구 (연세대학교 의과대학 심장혈관병원 심장혈관 외과) ;
  • 유경종 (연세대학교 의과대학 심장혈관병원 심장혈관 외과)
  • Published : 2002.11.01

Abstract

Recently, the number of coronary artery bypass surgery(CABG) is increasing according to the increasing incidence of coronary artery disease. However, CABG is not a definite corrective surgery; therefore, in some patients, redo-CABG may be required. We retrospectively reviewed our redo-CABG experiences to help future redo-CABG. Material and Method: From January 1991 to April 2001, 14 cases of redo-CABG were performed in Yonsei Cardiovascular Center(M:F=12:2) and mean age was 61,7 $\pm$ 7.1(47-72) years. Mean time from 1st. CABG to redo-CABG was 121.9 $\pm$ 50.5(6.1-179.6) months. Thirteen cases were conventional on-pump CABG and one case was off-pump CABG. In two patients, mitral valve re-replacement and mitral valve repair were performed each. All redo-CABG were performed through mid-sternotomy. During redo-CABG, left internal mammary artery and saphenous vein grafts were used in 6 patients, left internal mammary artery and left radial artery grafts were used in 2 patients, left internal mammary artery and gastroepiploic artery were used in one patient and only greater saphenous veins were used in 5 cases(In one case, cephalic vein was also used). The number of mean distal anastomosis was 2.1 $\pm$ 0.9(1-4). Result: There were no operative death and no perioperative myocardial infarctions and cerebrovascular accidents or other heart related complications. Mean follow up duration was 40.1 $\pm$ 38.6(1.1-118.5) months. During follow up period, angina was re-developed in one patient 13 months after operation. Two patients died of end-stage renal failure 14.8 months and 116.3 months after redo-CABG, respectively. During follow up period, coronary angiography was performed in 3 patients, and all grafts were patent. At last follow up, mean Canadian class was 1.3. Kaplan-Meier survival at 9 years was 90.0 $\pm$ 9.5% and event free survival at 9 years was 71.4 $\pm$ 6.9%. Conclusion: After redo-CABG, all patients improved their angina symptom and daily activity. And long-term survival after redo-CABG was excellent. Therefore, if patients have indications for redo-CABG, thenredo-CABG must be strongly recommended and performed.

최근 들어 관상동맥 질환자의 수가 급격히 증가하면서 관상동맥 우회술의 수도 급격히 증가하고 있다. 그러나 관상동맥 우회술은 영구적인 완전 교정술이 아니기 때문에 재수술이 필요할 수 있다. 저자들은 관상 동맥우회 재수술의 임상결과를 후향적 방법으로 고찰하여 보았다. 대상 및 방법: 1991년 1월부터 2001년 4월까지 연세 심장혈관 병원에서 관상동맥우회 재수술을 시행 받은 14명을 대상으로 하였으며 (남자:12명, 여자:2명), 평균 연령은 61.7$\pm$7.1(47~72세) 세였다. 처음 수술 받은 날부터 재수술시까지의 평균 기간은 121.9$\pm$50.5(6.1~179.6 개월) 개월이었다. 재수술시 13명의 환자들은 일반적인 심폐체외순환하에 수술을 하였고 1명의 환자는 심폐체외순환 없이 수술을 시행하였다. 동반 수술로는 1명의 환자에서 승모판막 재치환술을 시행하였고, 1명의 환자에서는 승모판막륜 성형술을 시행하였다. 재수술은 모두 정중 흉골절개하에 시행하였다. 재수술시 사용한 이식 혈관은 좌측 내흉동맥과 대 복재정맥을 사용한 경우가 6례, 좌측 내흉동맥과 좌측 요골 동맥을 사용한 경우가 2례, 좌측 내흉 동맥과 위장관 동맥을 사용한 경우가 1례, 대 복재정맥만을 사용한 경우가 5례(1례는 cephalic vein도 같이 사용) 있었으며, 평균 이식 편수는 2.1$\pm$0.9(1~4개) 개였다. 결과: 14명의 환자들 중에서 수술과 관련한 사망이나 조기 사망은 없었으며, 합병증은 신부전증, 호흡부전 및 경막하 출혈이 각각 1례 있었다. 평균 추적 관찰 기간은 40.1$\pm$38.6(1.1~l18.5) 개월 이었다. 추적기간 중 1명의 환자가 재수술 후 13개월에 협심증이 재발했고, 2명의 환자가 재수술 후 14.8개월 및 116.3개월에 만성 신부전증으로 사망하였다. 추적 기간 중에 3명의 환자에서 관상동맥 조영술을 시행하였는데 이식 혈관들은 모두 개존성을 보였다. 마지막 외래 내원시 생존 환자들의 평균 Canadian class는 1.3이었고, 재수술 후 9년까지 사건(event)이 없을 확률은 71.4$\pm$6.9%였으며, 생존률은 90.0$\pm$9.5%였다. 결론: 관상동맥우회 재수술은 수술 후에 환자 상태의 호전을 기대할 수 있고, 장기간의 생존률도 우수하기에, 수술적응이 된다면 수술을 적극적으로 고려하여야 할 것으로 생각한다.

Keywords

References

  1. J Thorac Cardiovasc Surg v.92 Predictors of reoperation after myocardial revascularization Cosgrove DM;Loop FD;Lytle BW(et al.)
  2. Circulation v.70 no.SUP. Comparison of late change in internal mammary artery and saphenous vein grafts in two consecutive series of patients 10 years after operation Grondin CM;Campeau L;Lesperance J;Enjalbert M;Bourassa
  3. J Thorac Cardiovasc Surg v.91 Coronary bypass graft fate Fitzibbon GM;Leach AJ;Keon WJ;Burton JR;Kafka HP
  4. J Thorac Cardiovasc Surg v.93 Fifteen hundred coronary reoperations Lytle BW;Loop FD;Cosgrove DM(et al.)
  5. Ann Thorac Surg v.56 Risk analysis of primary versus reoperative coronary artery bypass grafting Rosengart T https://doi.org/10.1016/0003-4975(93)91139-E
  6. Ann thorac Surg v.58 Reoperative Coronary Grafting: Changing Patient Profiles, Operative Indications, Techniques and Results Akins CW;Buckely MJ;Daggett WM(et al.) https://doi.org/10.1016/0003-4975(94)92208-X
  7. Eur. J Cardiothorac Surg v.11 Reoperative coronary artery bypass procedure: risk factors for early mortality and late survival Christenson JT;Schmuziger M;Simonet F https://doi.org/10.1016/S1010-7940(96)01030-5
  8. J Thorac Cardiovasc Surg v.110 Determinants of operative mortality in reperative coronary artery bypass grafting He GW;Acuff TE;Ryan WH;He YH;Mack MJ https://doi.org/10.1016/S0022-5223(05)80164-3
  9. Ann Thorac Surg v.68 Catastrophic hemorrhage on sternal reentry: Still a freaded complication Follis FM;Pett SB;Miller KB;Wong RS;Temes RT;Wernly JA https://doi.org/10.1016/S0003-4975(99)01173-X
  10. Eur J Cardiothoraci Surg v.12 Lateral MIDCAB grafting via limited posterior thoracotomy Fonger JD;Doty JR;Sussman MS;Salmon NW https://doi.org/10.1016/S1010-7940(97)00177-2
  11. Ann Thorac Surg v.71 Off-pump reoperative coronary artery bypass grafting by thoracotomy: Patient selection and operative technique Azoury FM;Gillinov AM;Lytle BW;Smedira NG;Sabik JF https://doi.org/10.1016/S0003-4975(01)02617-0
  12. Ann Thorac Surg v.43 Atheroembolic perioperative infarction during repaeat coronary bypass surgery: Angiographic documentation in a survivor FitzGibbon GM;Keon WJ https://doi.org/10.1016/S0003-4975(10)60403-1
  13. J Thorac Cardiovasc Surg v.87 Reoperation in patients with patent atherosclerotic coronary vein grafts Grondin CM;Pomar JL;Hebert Y(et al.)
  14. Ann Thorac Surg v.67 Injury to a patent left internal thoracic artery gratf at coronary reoperation Gillinov AM;Casselman FP;Lytle BW(et al.) https://doi.org/10.1016/S0003-4975(99)00009-0
  15. J Card Surg v.9 Technique for reoperative median sternotomy in the presence of a patent internal mammary artery graft Elami A;Laks H;Merian G https://doi.org/10.1111/j.1540-8191.1994.tb00837.x
  16. J Thorac Cardiovasc Surg v.121 Reoperative coronary bypass surgery: Effect of patent grafts and retrograde cardioplegia Borger MA;Rao V;Weisel RD(et al.) https://doi.org/10.1067/mtc.2001.111382
  17. Ann Thorac Surg v.69 Beating heart versus conventional single-vessel reoperative coronary artery bypass Stamou SC;Pfister AJ;Dangas G(et al.) https://doi.org/10.1016/S0003-4975(00)01177-2
  18. Ann Thorac Surg v.42 Management during reoperation of aortocoronary saphenous vein grafts with minimal atherosclerosis by angiography Marshall WG;Sffitz J;Kouchoukos NT https://doi.org/10.1016/S0003-4975(10)60511-5
  19. Ann Thorac Surg v.65 Should angiographically disease-free saphenous vein grafts be replaced at the time of redo coronary artery bypass grafting? Mehta ID;Weinberg J;Jones MF(et al.) https://doi.org/10.1016/S0003-4975(97)01192-2
  20. Cardivasc Surg v.9 Effective surgical management of high-risk coronary patients using preoperative intra-aortic balloon counterpulsation therapy Christenson JT;Schmuziger M;Simonet F https://doi.org/10.1016/S0967-2109(00)00151-4